Liquid perfluorocarbons as contrast agents for ultrasonography and 19F-MRI

Pharmaceutical Research

Volumn 27, Issue 1, 2010, Pages 1-16

  Díaz López, Raquel ^a,b   Tsapis, Nicolas ^a,b   Fattal, Elias ^a,b  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b CNRS   (France)

Author keywords

Emulsions; Liquid perfluorocarbons; MRI; Nanocapsules; Nanoemulsions; Ultrasonography; Ultrasound contrast agents

Indexed keywords

ALBUNEX; CONTRAST MEDIUM; ECHO CONTRAST MEDIUM; FLUORINE; FLUOROCARBON; NANOCAPSULE; PERFLEXANE; PERFLUORO 15 CROWN 5 ETHER; PERFLUORODECALIN; PERFLUORODICHLOROOCTANE; PERFLUORONONANE; PERFLUOROOCTYL BROMIDE; PERFLUOROPENTANE; PERFLUOROTRIBUTYLAMINE; PERFLUTREN; SHU 508; SONOVUE; UNCLASSIFIED DRUG;

BIOCOMPATIBILITY; CHEMICAL STRUCTURE; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG HALF LIFE; ECHOGRAPHY; EMULSION; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; MICROCAPSULE; NANOEMULSION; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REVIEW;

ANIMALS; CONTRAST MEDIA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FLUORINE; FLUOROCARBONS; HUMANS; MAGNETIC RESONANCE IMAGING; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE; NANOTECHNOLOGY; ULTRASONOGRAPHY;

EID: 72949093998     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-009-0001-5     Document Type: Review

References (110)

1. JG Riess 2002 Blood substitutes and other potential biomedical applications of fluorinated colloids J Fluorine Chem. 114 119 26
2. U Gross S Rudiger H Reichelt 1991 Perfluorocarbons-chemically inert but biologically-active J Fluorine Chem. 53 155 61
3. HJ Lehmler PM Bummer M Jay 1999 Liquid ventilation-a new way to deliver drugs to diseased lungs? Chemtech 29 7 12
4. MS Liuand DM Long 1977 Perfluoroctylbromide as a diagnostic contrast medium in gastroenterography Radiology 122 71 6
5. KC Lowe 1999 Perfluorinated blood substitutes and artificial oxygen carriers Blood Rev 13 171 84 10527269
6. PT Leese RJ Noveck JS Shorr CM Woods KE Flaim PE Keipert 2000 Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers Anesth Analg 91 804 11 11004030
7. RJ Noveck EJ Shannon PT Leese JS Shorr KE Flaim PE Keipert, et al. 2000 Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers Anesth Analg 91 812 22 11004031
8. DR Spahn 1999 Blood substitutes artificial oxygen carriers: perfluorocarbon emulsions Crit Care. 3 R93 7 11094488
9. KC Lowe 2003 Engineering blood: synthetic substitutes from fluorinated compounds Tissue Eng 9 389 99 12857407
10. GW Gross JS Greenspan WW Fox SD Rubenstein MR Wolfson TH Shaffer 1995 Use of liquid ventilation with perflubron during extracorporeal membrane-oxygenation-chest radiographic appearances Radiology 194 717 20 7862968
11. JA Lozano JA Castro I Rodrigo 2001 Partial liquid ventilation with perfluorocarbons for treatment of ARDS in burns Burns 27 635 42 11525860
12. I Hamon 1997 Liquid ventilation: a new mode of ventilation in neonatology? Arch Pediatr 4 176 80 9097831
13. RF Mattrey DM Long F Multer R Mitten CB Higgins 1982 Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography Radiology 145 755 8 7146408
14. SW Young DR Enzmann DM Long HH Muller 1981 Perfluoroctylbromide contrast enhancement of malignant neoplasms: preliminary observations AJR Am J Roentgenol 137 141 6 6787865
15. AL Klibanov 2007 Ultrasound molecular imaging with targeted microbubble contrast agents J Nucl Cardiol 14 876 84 18022115
16. RF Mattrey 1994 The potential role of perfluorochemicals (PFCs) in diagnostic imaging Artif Cells Blood Substit Immobil Biotechnol 22 295 313 8087248
17. EG Schutt DH Klein RM Mattrey JG Riess 2003 Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals Angew Chem Int Edit 42 3218 35
18. Y Liu H Miyoshi M Nakamura 2006 Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery J Control Release 114 89 99 16824637
19. PA Dijkmans LJ Juffermans RJ Musters A van Wamel FJ ten Cate W van Gilst, et al. 2004 Microbubbles and ultrasound: from diagnosis to therapy Eur J Echocardiogr 5 245 56 15219539
20. GM Lanzaand SA Wickline 2003 Targeted ultrasonic contrast agents for molecular imaging and therapy Curr Probl Cardiol 28 625 53
21. S Hernotand AL Klibanov 2008 Microbubbles in ultrasound-triggered drug and gene delivery Adv Drug Deliv Rev 60 1153 66
22. BE Oeffinger MA Wheatley 2004 Development and characterization of a nano-scale contrast agent Ultrasonics 42 343 7 15047309
23. PC Sontum 2008 Physicochemical characteristics of Sonazoid (TM), a new contrast agent for ultrasound imaging Ultrasound Med Biol 34 824 33 18255220
24. Goldberg B. Ultrasound contrast agents. London: Dunitz; 2001.
25. JR Lindner 2004 Microbubbles in medical imaging: current applications and future directions Nat Rev Drug Discov 3 527 33 15173842
26. F Calliada R Campani O Bottinelli A Bozzini MG Sommaruga 1998 Ultrasound contrast agents: basic principles Eur J Radiol 27 Suppl 2 S157 60 9652516
27. EG Grant 2001 Sonographic contrast agents in vascular imaging Seminars in Ultrasound Ct and Mri 22 25 41
28. FC Ngo CS Hall JN Marsh RW Fuhrhop JS Allen P Brown, et al. 2000 Evaluation of liquid perfluorocarbon nanoparticles as a blood pool contrast agent utilizing power Doppler harmonic imaging 2000 Ieee Ultrasonics Symposium Proceedings 1 and 2 1931 4
29. SA Wickline M Hughes FC Ngo CS Hall JN Marsh PA Brown, et al. 2002 Blood contrast enhancement with a novel, non-gaseous nanoparticle contrast agent Acad Radiol. 9 S290 3 12188251
30. D Bokor 2000 Diagnostic efficacy of SonoVue Am J Cardiol 86 19G 24 10997347
31. DW Kitzman ME Goldman LD Gillam JL Cohen GP Aurigemma JS Gottdiener 2000 Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images Am J Cardiol 86 669 74 10980221
32. JR Lindner J Song AR Jayaweera J Sklenar S Kaul 2002 Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration J Am Soc Echocardiogr 15 396 403 12019422
33. JL Cohen J Cheirif DS Segar LD Gillam JS Gottdiener E Hausnerova, et al. 1998 Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent. Results of a phase III Multicenter Trial J Am Coll Cardiol 32 746 52 9741522
34. JM Correas L Bridal A Lesavre A Mejean M Claudon O Helenon 2001 Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts Eur Radiol 11 1316 28 11519538
35. JA Straub DE Chickering CC Church B Shah T Hanlon H Bernstein 2005 Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography J Control Release 108 21 32 16126299
36. W Cui J Bei S Wang G Zhi Y Zhao X Zhou, et al. 2005 Preparation and evaluation of poly(L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography J Biomed Mater Res B Appl Biomater 73 171 8 15678494
37. DM El-Sherif MA Wheatley 2003 Development of a novel method for synthesis of a polymeric ultrasound contrast agent J Biomed Mater Res A 66 347 55 12889005
38. S Quay 1994 Microbubble-based ultrasound contrast agents: the role of gas selection in microbubble persistence J Ultrasound Med 13 S9
39. RF Mattrey FW Scheible BB Gosink GR Leopold DM Long CB Higgins 1982 Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material Radiology 145 759 62 7146409
40. H Ragde GM Kenny GP Murphy K Landin 1997 Transrectal ultrasound microbubble contrast angiography of the prostate Prostate 32 279 83 9288187
41. S Ge GG Giraud T Shiota GA Pantely J Xu Z Gong, et al. 1995 Microcirculatory flow dynamics during peripheral intravenous injection of echogentm: microscopic visualization of mesenteric microcirculatory flow with simultaneous transthoracic echo imaging in cats J Am Coll Cardiol 25 227A 227A
42. B Cotter A Duong A Raisinghani S Keramati E Mahmud OL Kwan, et al. 1996 Myocardial opacification by low doses EchoGen in patients: assessment of preactivation by closed syringe suction J Am Coll Cardiol 27 126 126
43. P Nihoyannopoulos L Rallidis J-M Correas SC Quay 1996 Myocardial enhancement following peripheral intravenous injection of activated QW3600 (EchoGen) in normal human volunteers J Am Coll Cardiol 27 378 378
44. P Grayburn 1997 Perflenapent emulsion (EchoGen): a new long-acting phase-shift agent for contrast echocardiography Clin Cardiol 20 I12 8 9383597
45. LM Kornmann DMJ Curfs E Hermeling I van der Made MPJ de Winther RS Reneman, et al. 2008 Perfluorohexane-loaded macrophages as a novel ultrasound contrast agent: a feasibility study Mol Imaging Biol 10 264 70 18536974
46. P Saha B Modarai J Humphries K Mattock M Waltham KG Burnand, et al. 2009 The monocyte/macrophage as a therapeutic target in atherosclerosis Curr Opin Pharmacol 9 109 18 19230773
47. R Gref Y Minamitake MT Peracchia V Trubetskoy V Torchilin R Langer 1994 Biodegradable long-circulating polymeric nanospheres Science 263 1600 3 8128245
48. F Yuan M Dellian D Fukumura M Leunig DA Berk VP Torchilin, et al. 1995 Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res 55 3752 6 7641188
49. R Gref M Luck P Quellec M Marchand E Dellacherie S Harnisch, et al. 2000 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf B Biointerfaces 18 301 13 10915952
50. R Pasqualini W Arap DM McDonald 2002 Probing the structural and molecular diversity of tumor vasculature Trends Mol Med 8 563 71 12470989
51. GM Lanza KD Wallace MJ Scott WP Cacheris DR Abendschein DH Christy, et al. 1996 A novel site-targeted ultrasonic contrast agent with broad biomedical application Circulation 94 3334 40 8989148
52. GM Lanza DR Abendschein CS Hall MJ Scott DE Scherrer A Houseman, et al. 2000 In vivo molecular imaging of stretch-induced tissue factor in carotid arteries with ligand-targeted nanoparticles J Am Soc Echocardiogr 13 608 14 10849515
53. RM Winslow 2000 Blood substitutes Adv Drug Deliv Rev 40 131 42 10837785
54. CS Hall JN Marsh MJ Scott PJ Gaffney SA Wickline GM Lanza 2001 Temperature dependence of ultrasonic enhancement with a site-targeted contrast agent J Acoust Soc Am 110 1677 84 11572376
55. JN Marsh CS Hall SA Wickline GM Lanza 2002 Temperature dependence of acoustic impedance for specific fluorocarbon liquids J Acoust Soc Am 112 2858 62 12509007
56. JN Marsh CS Hall MJ Scott RW Fuhrhop PJ Gaffney SA Wickline, et al. 2002 Improvements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line model IEEE Trans Ultrason Ferroelectr Freq Control 49 29 38 11833889
57. JN Marsh KC Partlow DR Abendschein MJ Scott GM Lanza SA Wickline 2007 Molecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopes Ultrasound Med Biol 33 950 8 17434667
58. MS Hughes JN Marsh H Zhang AK Woodson JS Allen EK Lacy, et al. 2006 Characterization of digital waveforms using thermodynamic analogs: Detection of contrast-targeted tissue in vivo IEEE Trans Ultrason Ferroelectr Freq Control 53 1609 16 16964911
59. MS Hughes JE McCarthy JN Marsh JM Arbeit RG Neumann RW Fuhrhop, et al. 2007 Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging J Acoust Soc Am 121 3542 57 17552706
60. MS Hughes JN Marsh JM Arbeit RG Neumann RW Fuhrhop KD Wallace, et al. 2009 Application of Renyi entropy for ultrasonic molecular imaging J Acoust Soc Am 125 3141 5 19425656
61. O Couture PD Bevan E Cherin K Cheung PN Burns FS Foster 2006 Investigating perfluorohexane particles with high-frequency ultrasound Ultrasound Med Biol 32 73 82 16364799
62. O Couture PD Bevan E Cherin K Cheung PN Burns FS Foster 2006 A model for reflectivity enhancement due to surface bound submicrometer particles Ultrasound Med Biol 32 1247 55 16875958
63. DM El-Sherif JD Lathia NT Le MA Wheatley 2004 Ultrasound degradation of novel polymer contrast agents J Biomed Mater Res A 68 71 8 14661251
64. E Pisani N Tsapis J Paris V Nicolas L Cattel E Fattal 2006 Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterization Langmuir 22 4397 402 16618193
65. E Pisani N Tsapis B Galaz M Santin R Berti N Taulier, et al. 2008 Perfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imaging Adv Funct Mater 18 2963 71
66. E Pisani E Fattal J Paris C Ringard V Rosilio N Tsapis 2008 Surfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: Influence of polymer adsorption at the dichloromethane-water interface J Colloid Interface Sci 326 66 71 18674774
67. AM Reed DK Gilding 1981 Biodegradable polymers for use in surgery-poly(glycolic)/poly(Iactic acid) homo and copolymers: 2. In vitro degradation Polymer 22 494 8
68. K Yamaguchiand JM Anderson 1993 Invivo biocompatibility studies of medisorb(R) 65/35 D. L-lactide glycolide copolymer microspheres J Control Release 24 81 93
69. DE Owens 3rd NA Peppas 2006 Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int J Pharm 307 93 102 16303268
70. JM Harris RB Chess 2003 Effect of pegylation on pharmaceuticals Nat Rev Drug Discov 2 214 21 12612647
71. R Diaz-Lopez N Tsapis D Libong P Chaminade C Connan MM Chehimi, et al. 2009 Phospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agents Biomaterials 30 1462 72 19097640
72. JY Fang CF Hung SC Hua TL Hwang 2009 Acoustically active perfluorocarbon nanoemulsions as drug delivery carriers for camptothecin: drug release and cytotoxicity against cancer cells Ultrasonics 49 39 46 18554679
73. N Rapoport Z Gao A Kennedy 2007 Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy J Natl Cancer Inst 99 1095 106 17623798
74. Z Gao AM Kennedy DA Christensen NY Rapoport 2008 Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy Ultrasonics 48 260 70 18096196
75. H Maeda 2001 The enhanced permeability and Retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting Advan Enzyme Regul. 41 189 207
76. I Uchegbu 1999 Parenteral drug delivery: 1 Pharm J 263 309 18
77. EA Waters SA Wickline 2008 Contrast agents for MRI Basic Res Cardiol 103 114 21 18324367
78. S McKieand J Brittenden 2005 (ii) Basic science: magnetic resonance imaging Curr Orthop 19 13 9
79. G-P Yan L Robinson P Hogg 2007 Magnetic resonance imaging contrast agents: overview and perspectives Radiography 13 e5 19
80. A Hengererand J Grimm 2006 Molecular magnetic resonance imaging Biomed Imaging Intervention J 2 e8
81. SD Caruthers AM Neubauer FD Hockett R Lamerichs PM Winter MJ Scott, et al. 2006 In vitro demonstration using F-19 magnetic resonance to augment molecular imaging with paramagnetic perfluorocarbon nanoparticles at 1.5 Tesla Invest Radiol 41 305 12 16481914
82. GN Holland PA Bottomley WS Hinshaw 1977 19F magnetic resonance imaging J Magn Reson 28 133 6
83. A Kimura M Narazaki Y Kanazawa H Fujiwara 2004 19F Magnetic resonance imaging of perfluorooctanoic acid encapsulated in liposome for biodistribution measurement Magn Reson Imaging 22 855 60 15234455
84. R Schwarz M Schuurmans J Seelig B Kunnecke 1999 19F-MRI of perfluorononane as a novel contrast modality for gastrointestinal imaging Magn Reson Med 41 80 6 10025614
85. RP Mason RL Nunnally PP Antich 1991 Tissue oxygenation: a novel determination using 19F surface coil NMR spectroscopy of sequestered perfluorocarbon emulsion Magn Reson Med 18 71 9 2062243
86. LC Clark Jr JL Ackerman SR Thomas RW Millard RE Hoffman RG Pratt, et al. 1984 Perfluorinated organic liquids and emulsions as biocompatible NMR imaging agents for 19F and dissolved oxygen Adv Exp Med Biol 180 835 45 6534151
87. RP Mason H Shukla PP Antich 1992 Oxygent(Tm)-a novel probe of tissue oxygen-tension Biomaterials Artificial Cells and Immobilization Biotechnology 20 929 32
88. RP Mason H Shukla PP Antich 1993 In vivo oxygen-tension and temperature-simultaneous determination using f-19 nmr-spectroscopy of perfluorocarbon Magn Reson Med 29 296 302 8450738
89. HP Shukla RP Mason C Storey FMH Jeffrey PP Antich 1992 The relationship of oxygen-tension and myocardial mechanical function-a F-19 Nmr-study Circulation 86 693 693
90. HP Shukla RP Mason N Bansal PP Antich 1996 Regional myocardial oxygen tension: F-19 MRI of sequestered perfluorocarbon Magn Reson Med 35 827 33 8744009
91. HP Shukla RP Mason DE Woessner PP Antich 1995 Comparison of 3 commercial perfluorocarbon emulsions as high-field F-19 Nmr probes of oxygen-tension and temperature J Magn Reson B 106 131 41
92. SR Thomas RG Pratt RW Millard RC Samaratunga Y Shiferaw AJ McGoron, et al. 1996 In vivo PO2 imaging in the porcine model with perfluorocarbon F-19 NMR at low field Magn Reson Imaging 14 103 14 8656982
93. RP Mason 1994 Non-invasive physiology: 19F NMR of perfluorocarbons Artif Cells Blood Substit Immobil Biotechnol 22 1141 53 7849916
94. D Eidelberg G Johnson D Barnes PS Tofts D Delpy D Plummer, et al. 1988 19F NMR imaging of blood oxygenation in the brain Magn Reson Med 6 344 52 3362067
95. JE Fishman PM Joseph TF Floyd B Mukherji HA Sloviter 1987 Oxygen-sensitive 19F NMR imaging of the vascular system in vivo Magn Reson Imaging 5 279 85 3657400
96. AM Morawski PM Winter X Yu RW Fuhrhop MJ Scott F Hockett, et al. 2004 Quantitative "magnetic resonance immunohistochemistry" with ligand-targeted (19)F nanoparticles Magn Reson Med 52 1255 62 15562481
97. P Winter P Athey G Kiefer G Gulyas K Frank R Fuhrhop, et al. 2005 Improved paramagnetic chelate for molecular imaging with MRI. Proceedings of the Fifth International Conference on Scientific and Clinical Apllications of Magnetic Carriers J Magn Magn Mater 293 540 5
98. AM Neubauer H Sim PM Winter SD Caruthers TA Williams JD Robertson, et al. 2008 Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging Magn Reson Med 60 1353 61 19025903
99. AM Neubauer SD Caruthers FD Hockett T Cyrus JD Robertson JS Allen, et al. 2007 Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents J Cardiovasc Magn Reson 9 565 73 17365236
100. KC Partlow J Chen JA Brant AM Neubauer TE Meyerrose MH Creer, et al. 2007 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons Faseb J 21 1647 54 17284484
101. J Ruiz-Cabello P Walczak DA Kedziorek VP Chacko AH Schmieder SA Wickline, et al. 2008 In vivo "hot spot" MR imaging of neural stem cells using fluorinated nanoparticles Magn Reson Med 60 1506 11 19025893
102. AH Schmieder SD Caruthers H Zhang TA Williams JD Robertson SA Wickline, et al. 2008 Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model Faseb J 22 4179 89 18697838
103. EA Waters J Chen JS Allen H Zhang GM Lanza SA Wickline 2008 Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS J Cardiovasc Magn Reson 10 43 18817557
104. ET Ahrens R Flores HY Xu PA Morel 2005 In vivo imaging platform for tracking immunotherapeutic cells Nat Biotechnol 23 983 7 16041364
105. M Srinivas PA Morel LA Ernst DH Laidlaw ET Ahrens 2007 Fluorine-19 MRI for visualization and quantification of cell migration in a diabetes model Magn Reson Med 58 725 34 17899609
106. JM Janjic M Srinivas DKK Kadayakkara ET Ahrens 2008 Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection J Am Chem Soc 130 2832 41 18266363
107. U Flogel Z Ding H Hardung S Jander G Reichmann C Jacoby, et al. 2008 In vivo monitoring of inflammation after cardiac and cerebral ischemia by fluorine magnetic resonance imaging Circulation 118 140 8 18574049
108. AG Webb M Wong KJ Kolbeck R Magin KS Suslick 1996 Sonochemically produced fluorocarbon microspheres: a new class of magnetic resonance imaging agent J Magn Reson Imaging 6 675 83 8835962
109. AM Nystrom JW Bartels W Du KL Wooley 2009 Perfluorocarbon-loaded shell crosslinked knedel-like nanoparticles: lessons regarding polymer mobility and self-assembly J Polym Sci A-Polym Chem 47 1023 37
110. Kaneda MM, Caruthers S, Lanza GM, Wickline SA. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics. Ann Biomed Eng. 2009.